García-Otero, X.; Díaz-Tomé, V.; Varela-Fernández, R.; Martín-Pastor, M.; González-Barcia, M.; Blanco-Méndez, J.; Mondelo-García, C.; Bermudez, M.A.; Gonzalez, F.; Aguiar, P.;
et al. Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop. Pharmaceutics 2021, 13, 149.
https://doi.org/10.3390/pharmaceutics13020149
AMA Style
García-Otero X, Díaz-Tomé V, Varela-Fernández R, Martín-Pastor M, González-Barcia M, Blanco-Méndez J, Mondelo-García C, Bermudez MA, Gonzalez F, Aguiar P,
et al. Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop. Pharmaceutics. 2021; 13(2):149.
https://doi.org/10.3390/pharmaceutics13020149
Chicago/Turabian Style
García-Otero, Xurxo, Victoria Díaz-Tomé, Rubén Varela-Fernández, Manuel Martín-Pastor, Miguel González-Barcia, José Blanco-Méndez, Cristina Mondelo-García, Maria A. Bermudez, Francisco Gonzalez, Pablo Aguiar,
and et al. 2021. "Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop" Pharmaceutics 13, no. 2: 149.
https://doi.org/10.3390/pharmaceutics13020149
APA Style
García-Otero, X., Díaz-Tomé, V., Varela-Fernández, R., Martín-Pastor, M., González-Barcia, M., Blanco-Méndez, J., Mondelo-García, C., Bermudez, M. A., Gonzalez, F., Aguiar, P., Fernández-Ferreiro, A., & Otero-Espinar, F. J.
(2021). Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop. Pharmaceutics, 13(2), 149.
https://doi.org/10.3390/pharmaceutics13020149